Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Control of death receptor ligand activity by posttranslational modifications

(2010) R. Weinlich et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer

(2010) Jean-Charles Soria et al.   JOURNAL OF CLINICAL ONCOLOGY

“Combination-oriented molecular-targeting prevention” of cancer: a model involving the combination of TRAIL and a DR5 inducer

(2010) Tatsushi Yoshida et al.   Environmental Health and Preventive Medicine

Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF- B and Upregulation of TRAIL Receptors

(2009) A. M. Kamat et al.   CANCER RESEARCH

Lactobacillus rhamnosus GGinduces tumor regression in mice bearing orthotopic bladder tumors

(2009) Shih Wee Seow et al.   CANCER SCIENCE

Inhibition of Urinary Bladder Carcinogenesis by Broccoli Sprouts

(2008) R. Munday et al.   CANCER RESEARCH

Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells

(2008) Hiroya Taniguchi et al.   CANCER RESEARCH

History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story

(2007) Harry W. Herr et al.   JOURNAL OF UROLOGY